Abstract:Alzheimer's disease(AD) is a progressive neurodegenerative disorder that affects the elderly. Clinical studies have found that the amyloid deposits in the brain are aggravated along with the deterioration of the AD pathology. Indeed,Aβ peptides change particularly significantly early in the preclinical stage,and then detection of Aβ is of great importance in early diagnosis. Therefore,it is critical to diagnose and treat AD at the preclinical stage,and Aβ becomes the key target of international research. We also focus on risk factors for preclinical Alzheimer's disease,especially imbalance in lipid metabolism. Our current study presented a novel model with early onset of cognitive dysfunction by phospholipid transfer protein(PLTP) deficiency in APP/PS1ΔE9 mice without appearance of amyloid deposition. Dysfunction of PLTP might be a risk factor for the elevated Aβ in the preclinical stage of AD. We first found several potential functions of PLTP deficiency in the AD model mice:impairing cognitive performance;involvement in APP trafficking/processing and intracellular Aβ generation;inducing Aβ42 related alteration of BDNF. These established PLTP deficient AD mouse models could provide insights to early stages in AD like mild cognitive impairment(MCI) or preclinical AD(PCAD). Lipoprotein lipase(LPL) is expressed at high levels in hippocampal neurons,although its function is unclear. Lipoprotein lipase(LPL) is expressed at high levels in hippocampal neurons, although its function is unclear. We previously reported that LPL-deficient mice have learning and memory impairment and fewer synaptic vesicles in hippocampal neurons,but properties of synaptic activity in LPL-deficient neurons remain unexplored. In this study,we found reduced frequency of miniature excitatory postsynaptic currents(mEPSCs) and readily releasable pool(RRP) size in LPL-deficient neurons,which led to presynaptic dysfunction and plasticity impairment without altering postsynaptic activity. We demonstrated that synaptic vesicle recycling,which is known to play an important role in maintaining the RRP size in active synapses,is impaired in LPL-deficient neurons. Moreover,lipid assay revealed deficient docosahexaenoic acid(DHA) and arachidonic acid(AA) in the hippocampus of LPL-deficient mice;exogenous DHA or AA supplement partially restored synaptic vesicle recycling capability. These results suggest that impaired synaptic vesicle recycling results from defi cient DHA and AA and contributes to the presynaptic dysfunction and plasticity impairment in LPL-defi cient neurons. Accumulating evidence supported thatα-synuclein(α-syn) and ubiquitin C-terminal hydrolase L1(UCHL1) are required for normal synaptic and cognitive function. In this study,we found thatα-syn aggregated and the expression of UCHL1 decreased in the brain of LPL defi cient mice. Reduction of UCHL1 was resulted from nuclear retention of DNA cytosine-5-methyltransferase 1 in LPL knockout mice. Reverse changes were found in cultured cells overexpressing LPL. Furthermore,defi ciency of LPL increased ubiquitination ofα-syn. These results indicated that aggregation ofα-syn and reduction of UCHL1 expression in LPL-defi cient mice may affect synaptic function.

Lipoprotein Lipase Deficiency Leads to Α-Synuclein Aggregation and Ubiquitin C-terminal Hydrolase L1 Reduction.

Implication of Lipid Related Risk Factor for Preclinical Stage Alzheimer's Disease:Lipoprotein Lipase deficiency Leads to α-synuclein Aggregation and Impaired Learning and Memory Function

Impaired Synaptic Vesicle Recycling Contributes to Presynaptic Dysfunction in Lipoprotein Lipase-Deficient Mice.

Presynaptic Defects Underlying Impaired Learning and Memory Function in Lipoprotein Lipase-Deficient Mice

The UCH-L1 Gene Encodes Two Opposing Enzymatic Activities that Affect α-Synuclein Degradation and Parkinson's Disease Susceptibility

Implication of lipid metabolism disturbance and Alzheimer’s disease: focus on the lipoprotein lipase plays an important role in learning and memory function

Reducing the lipase LIPE in mutant α-synuclein mice improves Parkinson-like deficits and reveals sex differences in fatty acid metabolism

Ubiquitin Hydrolase Uch-L1 Rescues Β-Amyloid-induced Decreases in Synaptic Function and Contextual Memory

Immunoproteasome Subunit Low Molecular Mass Peptide 2 (LMP2) Deficiency Ameliorates LPS/Aβ1-42-Induced Neuroinflammation

Exploration of the Molecular Mechanism for Lipoprotein Lipase Expression Variations in SH-SY5Y Cells Exposed to Different Doses of Amyloid-Beta Protein

Lysosomal enzyme cathepsin D protects against alpha-synuclein aggregation and toxicity

Microglial LRRK2-mediated NFATc1 attenuates α-synuclein immunotoxicity in association with CX3CR1-induced migration and the lysosome-initiated degradation

Effects of Lanthionine Ketimine-5-Ethyl Ester on the α-Synucleinopathy Mouse Model

Low-density lipoprotein receptor-related protein 1 mediates α-synuclein transmission from the striatum to the substantia nigra in animal models of Parkinson's disease

Age- and Brain Region-Dependent Α-Synuclein Oligomerization is Attributed to Alterations in Intrinsic Enzymes Regulating Α-Synuclein Phosphorylation in Aging Monkey Brains

Lack of α-synuclein increases amyloid plaque accumulation in a transgenic mouse model of Alzheimer's disease

Synj1 Haploinsufficiency Causes Dopamine Neuron Vulnerability and Alpha-Synuclein Accumulation in Mice

Increased Oligomerization and Phosphorylation of Α-Synuclein Are Associated with Decreased Activity of Glucocerebrosidase and Protein Phosphatase 2A in Aging Monkey Brains

Aplp1 interacts with Lag3 to facilitate transmission of pathologic α-synuclein

Alpha-synuclein suppresses mitochondrial protease ClpP to trigger mitochondrial oxidative damage and neurotoxicity

A fragment of cell adhesion molecule L1 reduces amyloid-β plaques in a mouse model of Alzheimer’s disease